D. E. Shaw & Co., L.P. 13D and 13G filings for Ambrx Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-03-16 4:05 pm Purchase | 2023-03-06 | 13G | Ambrx Biopharma Inc. AMAM | D. E. Shaw & Co., L.P. | 22,050,000 8.200% | 22,050,000 (New Position) | Filing |